Virtual reality-based meditation is offering new hope to Veterans with treatment-resistant depression by providing an immersive and transformative experience. #MentalHealthCare ...
Teva completes enrollment for Phase 3 trial of mdc-TJK, a potential treatment for schizophrenia. Results expected in 2024. #schizophrenia #clinicaltrials